selected publications
- Targeting IL-27 and/or IL-10 in Experimental Murine Visceral Leishmaniasis. The American journal of tropical medicine and hygiene. 2020 Academic Article GET IT
- The Pretravel Consultation: Recent Updates. The American journal of medicine. 2020 Information Resource GET IT
-
Gamma Interferon-Regulated Chemokines in Leishmania donovani Infection in the Liver.
Infection and immunity.
2016
Academic Article
GET IT
Times cited: 18 -
IFN-γ-induced macrophage antileishmanial mechanisms in mice: A role for immunity-related GTPases, Irgm1 and Irgm3, in Leishmania donovani infection in the liver.
Experimental parasitology.
2015
Academic Article
GET IT
Times cited: 9 - Cutaneous Leishmaniasis: Current Treatment Practices in the USA for Returning Travelers. Current treatment options in infectious diseases. 2015 Academic Article GET IT
-
Granzyme-mediated regulation of host defense in the liver in experimental Leishmania donovani infection.
Infection and immunity.
2014
Academic Article
GET IT
Times cited: 3 -
Regulatory actions of Toll-like receptor 2 (TLR2) and TLR4 in Leishmania donovani infection in the liver.
Infection and immunity.
2013
Academic Article
GET IT
Times cited: 42 -
Leishmaniasis in the United States: treatment in 2012.
The American journal of tropical medicine and hygiene.
2012
Information Resource
GET IT
Times cited: 62 -
Treatment of visceral leishmaniasis in 2010: direction from Bihar State, India.
Future microbiology.
2010
Editorial Article
GET IT
Times cited: 13 -
Single-dose liposomal amphotericin B for visceral leishmaniasis in India.
The New England journal of medicine.
2010
Academic Article
GET IT
Times cited: 279 -
New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
2008
Academic Article
GET IT
Times cited: 154 -
Accelerated control of visceral Leishmania donovani infection in interleukin-6-deficient mice.
Infection and immunity.
2008
Academic Article
GET IT
Times cited: 38 -
Amphotericin B treatment for Indian visceral leishmaniasis: response to 15 daily versus alternate-day infusions.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
2007
Academic Article
GET IT
Times cited: 63 -
Responses to Leishmania donovani in mice deficient in interleukin-12 (IL-12), IL-12/IL-23, or IL-18.
Infection and immunity.
2006
Academic Article
GET IT
Times cited: 41 -
Responses to Leishmania donovani in mice deficient in both phagocyte oxidase and inducible nitric oxide synthase.
The American journal of tropical medicine and hygiene.
2006
Academic Article
GET IT
Times cited: 29 -
Visceral Leishmania donovani infection in interleukin-13-/- mice.
Infection and immunity.
2006
Academic Article
GET IT
Times cited: 19 -
Rapid, noninvasive diagnosis of visceral leishmaniasis in India: comparison of two immunochromatographic strip tests for detection of anti-K39 antibody.
Journal of clinical microbiology.
2006
Academic Article
GET IT
Times cited: 78 -
Sodium stibogluconate resistance in Leishmania donovani correlates with greater tolerance to macrophage antileishmanial responses and trivalent antimony therapy.
Parasitology.
2005
Academic Article
GET IT
Times cited: 21 -
Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasis.
Infection and immunity.
2005
Academic Article
GET IT
Times cited: 62 -
Prevention of relapse after chemotherapy in a chronic intracellular infection: mechanisms in experimental visceral leishmaniasis.
Journal of immunology (Baltimore, Md. : 1950).
2005
Academic Article
GET IT
Times cited: 40 -
Interleukin 10 receptor blockade--pentavalent antimony treatment in experimental visceral leishmaniasis.
Acta tropica.
2005
Academic Article
GET IT
Times cited: 19 -
A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan.
The Journal of experimental medicine.
2004
Academic Article
GET IT
Times cited: 186 -
Progress in the treatment of a neglected infectious disease: visceral leishmaniasis.
Expert review of anti-infective therapy.
2004
Information Resource
GET IT
Times cited: 47 -
Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
2004
Academic Article
GET IT
Times cited: 156 -
Modulation of T-cell costimulation as immunotherapy or immunochemotherapy in experimental visceral leishmaniasis.
Infection and immunity.
2003
Academic Article
GET IT
Times cited: 63 -
Immunoenhancement combined with amphotericin B as treatment for experimental visceral leishmaniasis.
Antimicrobial agents and chemotherapy.
2003
Academic Article
GET IT
Times cited: 59 -
Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis.
The Journal of infectious diseases.
2003
Academic Article
GET IT
Times cited: 73 -
A novel defect in interferon-gamma secretion in patients with refractory nontuberculous pulmonary mycobacteriosis.
Annals of internal medicine.
2003
Article
GET IT
Times cited: 24 -
Profound interferon gamma deficiency in patients with chronic pulmonary nontuberculous mycobacteriosis.
The American journal of medicine.
2002
Academic Article
GET IT
Times cited: 37 -
Kala-azar--progress against a neglected disease.
The New England journal of medicine.
2002
Editorial Article
GET IT
Times cited: 35 -
Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy.
Infection and immunity.
2002
Academic Article
GET IT
Times cited: 202 -
Noninvasive management of Indian visceral leishmaniasis: clinical application of diagnosis by K39 antigen strip testing at a kala-azar referral unit.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
2002
Academic Article
GET IT
Times cited: 55 -
Immunochromatographic strip-test detection of anti-K39 antibody in Indian visceral leishmaniasis.
Annals of tropical medicine and parasitology.
2002
Academic Article
GET IT
Times cited: 79 -
Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial.
BMJ (Clinical research ed.).
2001
Academic Article
GET IT
Times cited: 172 -
Evaluation of HIV-1 immunogen, an immunologic modifier, administered to patients infected with HIV having 300 to 549 x 10(6)/L CD4 cell counts: A randomized controlled trial.
JAMA.
2000
Academic Article
GET IT
Times cited: 152 -
Mononuclear cell recruitment, granuloma assembly, and response to treatment in experimental visceral leishmaniasis: intracellular adhesion molecule 1-dependent and -independent regulation.
Infection and immunity.
2000
Academic Article
GET IT
Times cited: 37 -
Suppression of posttreatment recurrence of experimental visceral Leishmaniasis in T-cell-deficient mice by oral miltefosine.
Antimicrobial agents and chemotherapy.
2000
Academic Article
GET IT
Times cited: 38 -
Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment.
Infection and immunity.
2000
Academic Article
GET IT
Times cited: 95 -
Interleukin-12 regulates the response to chemotherapy in experimental visceral Leishmaniasis.
The Journal of infectious diseases.
2000
Academic Article
GET IT
Times cited: 92 -
Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
2000
Academic Article
GET IT
Times cited: 513 -
Short-course of oral miltefosine for treatment of visceral leishmaniasis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
2000
Academic Article
GET IT
Times cited: 128 -
Short-course, cost-effective treatment with amphotericin B-fat emulsion cures visceral leishmaniasis.
Transactions of the Royal Society of Tropical Medicine and Hygiene.
2000
Academic Article
GET IT
Times cited: 49 -
Visceral leishmanicidal activity of hexadecylphosphocholine (miltefosine) in mice deficient in T cells and activated macrophage microbicidal mechanisms.
The Journal of infectious diseases.
2000
Academic Article
GET IT
Times cited: 64 -
Roles of endogenous gamma interferon and macrophage microbicidal mechanisms in host response to chemotherapy in experimental visceral leishmaniasis.
Infection and immunity.
2000
Academic Article
GET IT
Times cited: 102 -
Treatment of visceral leishmaniasis (kala-azar): a decade of progress and future approaches.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
2000
Information Resource
GET IT
Times cited: 104 -
Oral treatment of visceral leishmaniasis with miltefosine.
Annals of tropical medicine and parasitology.
1999
Academic Article
GET IT
Times cited: 103 -
Kala-azar as an AIDS-related opportunistic infection.
AIDS patient care and STDs.
1999
Information Resource
GET IT
Times cited: 29 -
Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani.
The Journal of experimental medicine.
1999
Academic Article
GET IT
Times cited: 369 -
Amphotericin B lipid complex in the management of antimony unresponsive Indian visceral leishmaniasis.
The Journal of the Association of Physicians of India.
1999
Academic Article
GET IT
Times cited: 20 -
Trial of oral miltefosine for visceral leishmaniasis.
Lancet (London, England).
1998
Academic Article
GET IT
Times cited: 216 - Treatment of antimony-unresponsive Indian visceral leishmaniasis with ultra-short courses of amphotericin-B-lipid complex. Annals of tropical medicine and parasitology. 1998 Academic Article GET IT
-
Therapeutic effect of interferon-gamma gene transfer in experimental visceral leishmaniasis.
The Journal of infectious diseases.
1998
Academic Article
GET IT
Times cited: 11 -
Atovaquone alone or with fluconazole as oral therapy for Indian kala-azar.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
1998
Academic Article
GET IT
Times cited: 7 -
Splenic cytokine responses in Indian kala-azar before and after treatment.
The Journal of infectious diseases.
1998
Academic Article
GET IT
Times cited: 108 -
Rapid accurate field diagnosis of Indian visceral leishmaniasis.
Lancet (London, England).
1998
Academic Article
GET IT
Times cited: 234 -
Costs of amphotericin B lipid complex for kala-azar.
Annals of internal medicine.
1998
Article
GET IT
Times cited: 1 - Response to interferon-gamma plus pentavalent antimony in Indian visceral leishmaniasis. The Journal of infectious diseases. 1997 Academic Article GET IT
-
Short-course, low-dose amphotericin B lipid complex therapy for visceral leishmaniasis unresponsive to antimony.
Annals of internal medicine.
1997
Academic Article
GET IT
Times cited: 103 -
Endogenous interleukin-12 regulates acquired resistance in experimental visceral leishmaniasis.
The Journal of infectious diseases.
1997
Academic Article
GET IT
Times cited: 84 -
Circulating T helper 1 (Th1) cell- and Th2 cell-associated cytokines in Indian patients with visceral leishmaniasis.
The American journal of tropical medicine and hygiene.
1997
Academic Article
GET IT
Times cited: 113 -
Intracellular antimicrobial activity in the absence of interferon-gamma: effect of interleukin-12 in experimental visceral leishmaniasis in interferon-gamma gene-disrupted mice.
The Journal of experimental medicine.
1997
Academic Article
GET IT
Times cited: 149 -
Behavior of visceral Leishmania donovani in an experimentally induced T helper cell 2 (Th2)-associated response model.
The Journal of experimental medicine.
1997
Academic Article
GET IT
Times cited: 63 -
Delivery of human interferon-gamma via gene transfer in vitro: prolonged expression and induction of macrophage antimicrobial activity.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
1996
Academic Article
GET IT
Times cited: 15 -
Current and future clinical applications of interferon-gamma in host antimicrobial defense.
Intensive care medicine.
1996
Information Resource
GET IT
Times cited: 51 -
Pentavalent antimony-mannan conjugate therapy of experimental visceral leishmaniasis.
The American journal of tropical medicine and hygiene.
1996
Academic Article
GET IT
Times cited: 13 -
Treatment of kala-azar with oral fluconazole.
Lancet (London, England).
1996
Article
GET IT
Times cited: 36 -
Induction of macrophage antiprotozoal activity by monocyte chemotactic and activating factor.
FEMS immunology and medical microbiology.
1996
Academic Article
GET IT
Times cited: 18 -
Models of relapse of experimental visceral leishmaniasis.
The Journal of infectious diseases.
1996
Academic Article
GET IT
Times cited: 22 -
Activity of oral atovaquone alone and in combination with antimony in experimental visceral leishmaniasis.
Antimicrobial agents and chemotherapy.
1996
Academic Article
GET IT
Times cited: 33 -
Cure of antimony-unresponsive Indian visceral leishmaniasis with amphotericin B lipid complex.
The Journal of infectious diseases.
1996
Academic Article
GET IT
Times cited: 68 -
Multiple host defense defects in failure of C57BL/6 ep/ep (pale ear) mice to resolve visceral Leishmania donovani infection.
Infection and immunity.
1996
Academic Article
GET IT
Times cited: 7 -
Effect of treatment with interferon-gamma alone in visceral leishmaniasis.
The Journal of infectious diseases.
1995
Academic Article
GET IT
Times cited: 52 -
Antimicrobial response of a T cell-deficient host to cytokine therapy: effect of interferon-gamma in experimental visceral leishmaniasis in nude mice.
The Journal of infectious diseases.
1995
Academic Article
GET IT
Times cited: 32 -
Gamma interferon in the treatment of Kala-azar and other forms of Leishmaniasis.
The Journal of the Association of Physicians of India.
1995
Information Resource
GET IT
Times cited: 2 -
Immunochemotherapy for a systemic intracellular infection: accelerated response using interferon-gamma in visceral leishmaniasis.
The Journal of infectious diseases.
1995
Academic Article
GET IT
Times cited: 67 -
Effect of granulocyte-macrophage colony-stimulating factor in experimental visceral leishmaniasis.
The Journal of clinical investigation.
1995
Academic Article
GET IT
Times cited: 77 -
Stavudine in patients with AIDS and AIDS-related complex: AIDS clinical trials group 089.
The Journal of infectious diseases.
1995
Academic Article
GET IT
Times cited: 51 -
Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis.
The Journal of experimental medicine.
1995
Academic Article
GET IT
Times cited: 127 -
Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12.
The Journal of experimental medicine.
1995
Academic Article
GET IT
Times cited: 535 -
Interferon-gamma and host antimicrobial defense: current and future clinical applications.
The American journal of medicine.
1994
Information Resource
GET IT
Times cited: 105 -
Successful treatment of refractory visceral leishmaniasis in India using antimony plus interferon-gamma.
The Journal of infectious diseases.
1994
Academic Article
GET IT
Times cited: 79 -
Role and effect of TNF-alpha in experimental visceral leishmaniasis.
Journal of immunology (Baltimore, Md. : 1950).
1994
Academic Article
GET IT
Times cited: 117 - Blood monocytes: differing effector role in experimental visceral versus cutaneous leishmaniasis. Parasitology today (Personal ed.). 1994 Academic Article GET IT
-
Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis.
Infection and immunity.
1994
Academic Article
GET IT
Times cited: 174 -
Circulating Borrelia burgdorferi in patients with acute Lyme disease: results of blood cultures and serum DNA analysis.
The Journal of infectious diseases.
1993
Academic Article
GET IT
Times cited: 31 -
Role and effect of IL-2 in experimental visceral leishmaniasis.
Journal of immunology (Baltimore, Md. : 1950).
1993
Academic Article
GET IT
Times cited: 95 -
Treatment of experimental visceral leishmaniasis in a T-cell-deficient host: response to amphotericin B and pentamidine.
Antimicrobial agents and chemotherapy.
1993
Academic Article
GET IT
Times cited: 46 -
Immunochemotherapy for visceral leishmaniasis: a controlled pilot trial of antimony versus antimony plus interferon-gamma.
The American journal of tropical medicine and hygiene.
1993
Academic Article
GET IT
Times cited: 67 -
Response to treatment for an intracellular infection in a T cell-deficient host: toxoplasmosis in nude mice.
The Journal of infectious diseases.
1993
Academic Article
GET IT
Times cited: 9 -
Effector role of blood monocytes in experimental visceral leishmaniasis.
Infection and immunity.
1993
Academic Article
GET IT
Times cited: 40 -
Malaria--the mime revisited: fifteen more years of experience at a New York City teaching hospital.
The American journal of medicine.
1992
Academic Article
GET IT
Times cited: 66 -
Acquired resistance and granuloma formation in experimental visceral leishmaniasis. Differential T cell and lymphokine roles in initial versus established immunity.
Journal of immunology (Baltimore, Md. : 1950).
1992
Academic Article
GET IT
Times cited: 109 -
L-arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes.
The Journal of infectious diseases.
1992
Academic Article
GET IT
Times cited: 143 -
Human immunodeficiency virus infection and bacteremic meningococcal pneumonia.
The Journal of infectious diseases.
1991
Article
GET IT
Times cited: 9 -
Use of granulocyte-macrophage colony stimulating factor for treatment of drug-induced agranulocytosis.
Reviews of infectious diseases.
1991
Article
GET IT
Times cited: 12 -
Response to chemotherapy in experimental visceral leishmaniasis: T cell-dependent but interferon-gamma- and interleukin-2-independent.
The Journal of infectious diseases.
1991
Academic Article
GET IT
Times cited: 17 -
Defect in the tissue cellular immune response: experimental visceral leishmaniasis in euthymic C57BL/6 ep/ep mice.
Infection and immunity.
1990
Academic Article
GET IT
Times cited: 16 -
Suppression of T-lymphocyte responses to Entamoeba histolytica antigen by immune sera.
Infection and immunity.
1990
Academic Article
GET IT
Times cited: 24 -
Effect of continuous administration of interferon-gamma in experimental visceral leishmaniasis.
The Journal of infectious diseases.
1990
Academic Article
GET IT
Times cited: 65 -
Fungal cholecystitis and AIDS.
The Journal of infectious diseases.
1990
Article
GET IT
Times cited: 10 -
Experimental visceral leishmaniasis: role of endogenous IFN-gamma in host defense and tissue granulomatous response.
Journal of immunology (Baltimore, Md. : 1950).
1989
Academic Article
GET IT
Times cited: 151 -
IFN-gamma and IFN-alpha induce the expression and synthesis of Leu 13 antigen by cultured human endothelial cells.
Journal of immunology (Baltimore, Md. : 1950).
1989
Academic Article
GET IT
Times cited: 31 -
Antigen-stimulated human interferon-gamma generation: role of accessory cells and their expressed or secreted products.
Clinical and experimental immunology.
1989
Academic Article
GET IT
Times cited: 9 -
Progression to AIDS in patients with lymphadenopathy or AIDS-related complex: reappraisal of risk and predictive factors.
The American journal of medicine.
1989
Academic Article
GET IT
Times cited: 34 -
Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis.
The Journal of clinical investigation.
1989
Academic Article
GET IT
Times cited: 105 -
Interferon-gamma and Mycobacterium avium-intracellulare infection.
The Journal of infectious diseases.
1989
Academic Article
GET IT
Times cited: 49 - Monocytes in HIV infection. Reviews of infectious diseases. 1989 Article GET IT
-
Role of tryptophan degradation in respiratory burst-independent antimicrobial activity of gamma interferon-stimulated human macrophages.
Infection and immunity.
1989
Academic Article
GET IT
Times cited: 174 -
In vivo killing of intracellular visceral Leishmania donovani by a macrophage-targeted hydrogen peroxide-generating system.
The Journal of infectious diseases.
1988
Academic Article
GET IT
Times cited: 10 -
Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients.
The American journal of medicine.
1988
Academic Article
GET IT
Times cited: 117 -
T4+ cell production of interferon gamma and the clinical spectrum of patients at risk for and with acquired immunodeficiency syndrome.
Archives of internal medicine.
1988
Academic Article
GET IT
Times cited: 30 -
Circulating interferon gamma in AIDS patients treated with interleukin-2.
The New England journal of medicine.
1988
Article
GET IT
Times cited: 15 -
Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis.
Journal of immunology (Baltimore, Md. : 1950).
1988
Academic Article
GET IT
Times cited: 133 -
The dynamics of granuloma formation in experimental visceral leishmaniasis.
The Journal of experimental medicine.
1988
Academic Article
GET IT
Times cited: 122 -
Immunochemotherapy for intracellular Leishmania donovani infection: gamma interferon plus pentavalent antimony.
The Journal of infectious diseases.
1988
Academic Article
GET IT
Times cited: 124 -
T lymphocyte responses to mycobacterial antigen in AIDS patients with disseminated Mycobacterium avium-Mycobacterium intracellulare infection.
Chest.
1988
Academic Article
GET IT
Times cited: 13 -
Interferon-gamma, the activated macrophage, and host defense against microbial challenge.
Annals of internal medicine.
1988
Information Resource
GET IT
Times cited: 327 -
Agonist and antagonist effects of interferon alpha and beta on activation of human macrophages. Two classes of interferon gamma receptors and blockade of the high-affinity sites by interferon alpha or beta.
The Journal of experimental medicine.
1988
Academic Article
GET IT
Times cited: 69 -
Macrophage activation in the acquired immunodeficiency syndrome.
Advances in experimental medicine and biology.
1988
Information Resource
GET IT
Times cited: 5 -
Antigen-induced human interferon-gamma production. Differential dependence on interleukin 2 and its receptor.
Journal of immunology (Baltimore, Md. : 1950).
1987
Academic Article
GET IT
Times cited: 35 -
Ribavirin pharmacodynamics in high-risk patients for acquired immunodeficiency syndrome.
Clinical pharmacology and therapeutics.
1987
Academic Article
GET IT
Times cited: 36 -
The local cellular immune response in experimental leishmaniasis.
Annales de l'Institut Pasteur. Immunology.
1987
Academic Article
GET IT
Times cited: 5 -
The role of gamma interferon in the generation of human macrophages cytotoxic for Entamoeba histolytica trophozoites.
The American journal of tropical medicine and hygiene.
1987
Academic Article
GET IT
Times cited: 35 -
In vitro and in vivo activation of human mononuclear phagocytes by interferon-gamma. Studies with normal and AIDS monocytes.
Journal of immunology (Baltimore, Md. : 1950).
1987
Academic Article
GET IT
Times cited: 107 -
Experimental visceral leishmaniasis: production of interleukin 2 and interferon-gamma, tissue immune reaction, and response to treatment with interleukin 2 and interferon-gamma.
Journal of immunology (Baltimore, Md. : 1950).
1987
Academic Article
GET IT
Times cited: 155 -
Presence of a macrophage-mediated suppressor cell mechanism during cell-mediated immune response in experimental visceral leishmaniasis.
Infection and immunity.
1986
Academic Article
GET IT
Times cited: 23 -
Oxygen-independent inhibition of intracellular Chlamydia psittaci growth by human monocytes and interferon-gamma-activated macrophages.
Journal of immunology (Baltimore, Md. : 1950).
1986
Academic Article
GET IT
Times cited: 31 -
Why is Listeria monocytogenes not a pathogen in the acquired immunodeficiency syndrome?.
Archives of internal medicine.
1986
Academic Article
GET IT
Times cited: 42 -
Patients treated for amebic liver abscess develop cell-mediated immune responses effective in vitro against Entamoeba histolytica.
Journal of immunology (Baltimore, Md. : 1950).
1986
Academic Article
GET IT
Times cited: 69 -
Cellular resistance to protozoal infection.
Annual review of medicine.
1986
Academic Article
GET IT
Times cited: 22 -
Immunologic developments in AIDS--1985.
The Year in immunology.
1986
Information Resource
GET IT
Times cited: 1 - Patients at risk for AIDS-related opportunistic infections. Clinical manifestations and impaired gamma interferon production. The New England journal of medicine. 1985 Academic Article GET IT
- Production of and in vitro response to interleukin 2 in the acquired immunodeficiency syndrome. The Journal of clinical investigation. 1985 Academic Article GET IT
-
Activation of tissue macrophages from AIDS patients: in vitro response of AIDS alveolar macrophages to lymphokines and interferon-gamma.
Journal of immunology (Baltimore, Md. : 1950).
1985
Academic Article
GET IT
Times cited: 81 -
Liver macrophages in murine listeriosis. Cell-mediated immunity is correlated with an influx of macrophages capable of generating reactive oxygen intermediates.
The Journal of experimental medicine.
1985
Academic Article
GET IT
Times cited: 86 -
Murine Kupffer cells. Mononuclear phagocytes deficient in the generation of reactive oxygen intermediates.
The Journal of experimental medicine.
1985
Academic Article
GET IT
Times cited: 121 -
Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma.
Journal of immunology (Baltimore, Md. : 1950).
1985
Academic Article
GET IT
Times cited: 253 -
Human mononuclear phagocyte antiprotozoal mechanisms: oxygen-dependent vs oxygen-independent activity against intracellular Toxoplasma gondii.
Journal of immunology (Baltimore, Md. : 1950).
1985
Academic Article
GET IT
Times cited: 116 - Immunologic developments in AIDS--1984. The Year in immunology. 1985 Academic Article GET IT
-
Activation of human macrophages. Comparison of other cytokines with interferon-gamma.
The Journal of experimental medicine.
1984
Academic Article
GET IT
Times cited: 313 - Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Annals of internal medicine. 1984 Academic Article GET IT
-
Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome.
The New England journal of medicine.
1984
Academic Article
GET IT
Times cited: 401 -
Cellular immunity and the acquired immune deficiency syndrome: failure to secrete lymphokines and gamma interferon.
Survey and synthesis of pathology research.
1984
Information Resource
GET IT
Times cited: 3 -
Macrophage activation: enhanced oxidative and antiprotozoal activity.
Contemporary topics in immunobiology.
1984
Information Resource
GET IT
Times cited: 14 -
Opportunistic infections and impaired cell-mediated immune responses in patients with the acquired immune deficiency syndrome.
Transactions of the American Clinical and Climatological Association.
1984
Academic Article
GET IT
Times cited: 5 -
Gamma-interferon is the factor in lymphokine that activates human macrophages to inhibit intracellular Chlamydia psittaci replication.
Journal of immunology (Baltimore, Md. : 1950).
1983
Academic Article
GET IT
Times cited: 84 -
Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine.
The Journal of clinical investigation.
1983
Academic Article
GET IT
Times cited: 310 -
Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.
The Journal of experimental medicine.
1983
Academic Article
GET IT
Times cited: 1542 -
Vancomycin serum levels and toxicity in chronic hemodialysis patients with Staphylococcus aureus bacteremia.
Clinical nephrology.
1983
Academic Article
GET IT
Times cited: 29 -
Killing of intracellular Leishmania donovani by human mononuclear phagocytes. Evidence for oxygen-dependent and -independent leishmanicidal activity.
The Journal of clinical investigation.
1983
Academic Article
GET IT
Times cited: 120 -
Lymphokine enhances oxygen-independent activity against intracellular pathogens.
The Journal of experimental medicine.
1983
Academic Article
GET IT
Times cited: 38 -
Suppression of macrophage antimicrobial activity by a tumor cell product.
Journal of immunology (Baltimore, Md. : 1950).
1983
Academic Article
GET IT
Times cited: 21 -
How protozoa evade intracellular killing.
Annals of internal medicine.
1983
Academic Article
GET IT
Times cited: 4 -
Lymphokine stimulated macrophages inhibit intracellular Chlamydia psittaci replication by mechanisms distinct from intracellular inhibition of Toxoplasma gondii replication.
Advances in experimental medicine and biology.
1983
Academic Article
GET IT
Times cited: 1 -
Macrophage oxygen-dependent killing of intracellular parasites: Toxoplasma and Leishmania.
Advances in experimental medicine and biology.
1983
Academic Article
GET IT
Times cited: 8 -
Cell-mediated immune response in experimental visceral leishmaniasis. I. Correlation between resistance to Leishmania donovani and lymphokine-generating capacity.
Journal of immunology (Baltimore, Md. : 1950).
1982
Academic Article
GET IT
Times cited: 87 -
Cell-mediated immune response in experimental visceral leishmaniasis. II. Oxygen-dependent killing of intracellular Leishmania donovani amastigotes.
Journal of immunology (Baltimore, Md. : 1950).
1982
Academic Article
GET IT
Times cited: 118 -
Pretreatment with phorbol myristate acetate inhibits macrophage activity against intracellular protozoa.
Journal of the Reticuloendothelial Society.
1982
Academic Article
GET IT
Times cited: 35 -
Regulation of arachidonic acid metabolism by macrophage activation.
The Journal of experimental medicine.
1982
Academic Article
GET IT
Times cited: 127 -
Effect of hydrocortisone on macrophage response to lymphokine.
Infection and immunity.
1982
Academic Article
GET IT
Times cited: 25 - An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. The New England journal of medicine. 1981 Academic Article GET IT
-
Susceptibility of Entamoeba histolytica to oxygen intermediates.
Molecular and biochemical parasitology.
1981
Academic Article
GET IT
Times cited: 39 -
Interaction of Leishmania with a macrophage cell line. Correlation between intracellular killing and the generation of oxygen intermediates.
The Journal of experimental medicine.
1981
Academic Article
GET IT
Times cited: 50 -
Susceptibility of Leishmania to oxygen intermediates and killing by normal macrophages.
The Journal of experimental medicine.
1981
Academic Article
GET IT
Times cited: 194 -
Tumor cell anti-oxidant defenses. Inhibition of the glutathione redox cycle enhances macrophage-mediated cytolysis.
The Journal of experimental medicine.
1981
Academic Article
GET IT
Times cited: 181 -
Macrophage oxygen-dependent antimicrobial activity. III. Enhanced oxidative metabolism as an expression of macrophage activation.
The Journal of experimental medicine.
1980
Academic Article
GET IT
Times cited: 140 -
Macrophage oxygen-dependent antimicrobial activity. IV. Role of endogenous scavengers of oxygen intermediates.
The Journal of experimental medicine.
1980
Academic Article
GET IT
Times cited: 47 -
Mononuclear phagocyte antimicrobial and antitumor activity: the role of oxygen intermediates.
The Journal of investigative dermatology.
1980
Academic Article
GET IT
Times cited: 21 -
Mycoplasma pneumoniae infection.
Archives of internal medicine.
1980
Article
GET IT
Times cited: 2 -
Macrophage oxygen-dependent antimicrobial activity. I. Susceptibility of Toxoplasma gondii to oxygen intermediates.
The Journal of experimental medicine.
1979
Academic Article
GET IT
Times cited: 126 -
Macrophage oxygen-dependent antimicrobial activity. II. The role of oxygen intermediates.
The Journal of experimental medicine.
1979
Academic Article
GET IT
Times cited: 143 -
Fever and pulmonary thromboembolism.
The American journal of medicine.
1979
Academic Article
GET IT
Times cited: 47 -
Factitious fever updated.
Archives of internal medicine.
1979
Academic Article
GET IT
Times cited: 5 -
Prophylaxis against ampicillin-associated diarrhea with a lactobacillus preparation.
American journal of hospital pharmacy.
1979
Academic Article
GET IT
Times cited: 148 - Colovesical fistula. JAMA. 1979 Article GET IT
- Uveitis and the immunologically compromised host. The New England journal of medicine. 1978 Article GET IT
-
Staphylococcus aureus carriage rate of patients receiving long-term hemodialysis.
Archives of internal medicine.
1978
Academic Article
GET IT
Times cited: 124 -
Septic bursitis.
Annals of internal medicine.
1978
Article
GET IT
Times cited: 2 -
Nafcillin therapy for Staphylococcus aureus endocarditis.
Antimicrobial agents and chemotherapy.
1978
Academic Article
GET IT
Times cited: 10 -
Transient autoimmune hemolytic anemia and pulmonary tuberculosis.
The New England journal of medicine.
1978
Article
GET IT
Times cited: 19 -
Streptococcus bovis bacteremia and underlying gastrointestinal disease.
Archives of internal medicine.
1978
Academic Article
GET IT
Times cited: 110 - Retinitis: a manifestation of primary or secondary cytomegalovirus infection?. Archives of internal medicine. 1978 Article GET IT
-
Aspergillosis.
JAMA.
1977
Article
GET IT
Times cited: 10 - Unusual pleocytosis in aseptic meningitis. The New England journal of medicine. 1977 Article GET IT
-
Liver biopsy septicemia.
Gastroenterology.
1977
Article
GET IT
Times cited: 5 -
Spontaneous bacterial empyema, pericarditis, and peritonitis in cirrhosis.
Gastroenterology.
1977
Article
GET IT
Times cited: 6 - Urinary temperature: a clue to early diagnosis of factitious fever. The New England journal of medicine. 1977 Academic Article GET IT
- Letter: "Goalpost fever". Annals of internal medicine. 1975 Academic Article GET IT
-
Pulmonary mucormycosis with massive fatal hemoptysis.
Chest.
1975
Academic Article
GET IT
Times cited: 33 -
The protean manifestations of Mycoplasma pneumoniae infection in adults.
The American journal of medicine.
1975
Information Resource
GET IT
Times cited: 186 -
Letter: Cardiac Munchausen syndrome.
Annals of internal medicine.
1974
Academic Article
GET IT
Times cited: 2 -
Disseminated paracoccidioidomycosis (South American blastomycosis) in the United States.
The American journal of medicine.
1974
Information Resource
GET IT
Times cited: 30 -
Exercise to prevent coronary heart disease. An experimental study of the effects of training on risk factors for coronary disease in men.
The American journal of medicine.
1969
Academic Article
GET IT
Times cited: 118